Home › Funds › Brighthouse › MetLife Russell 2000 Index Portfolio
Fund family: Brighthouse · Filed by Brighthouse Funds Trust II (CIK 710826) · SEC series S000006525
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 12,511 with, 1,879 against, 0 abstentions (not counted as with management); 58 items carried no recommendation; 14 split votes are in neither count. Shareholder proposals: 26 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Brighthouse | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 86.9% | 13,929 | 76.3% | 204,500 |
| Backed environmental and social shareholder proposals at US companies | n/a | 6 | 12.8% | 1,182 |
Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Brighthouse funds on 381 items (11.7% of the 3,261 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| SkyWest, Inc. | 2026-05-05 | Shareholder A shareholder proposal regarding collective bargaining policy. | For | ABSTAIN or AGAINST — 5 of 5 Brighthouse funds | Against | — |
| Marex Group plc | 2026-05-21 | Amend Articles of Association | Against | FOR — 4 of 4 Brighthouse funds | For | — |
| Marex Group plc | 2026-05-21 | Approve Capital Reduction by Cancellation and Extinguishment of the Deferred Shares | Against | FOR — 4 of 4 Brighthouse funds | For | — |
| Marex Group plc | 2026-05-21 | Approve Capital Reduction by Cancellation and Extinguishment of the Scheme Shares | Against | FOR — 4 of 4 Brighthouse funds | For | — |
| ArcBest Corporation | 2026-04-24 | Shareholder A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. | For | ABSTAIN or AGAINST — 4 of 4 Brighthouse funds | Against | — |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: David Hodgson | Withhold | FOR — 4 of 4 Brighthouse funds | For | Elected, 60.8% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: Jacqueline Kosecoff | Withhold | FOR — 4 of 4 Brighthouse funds | For | Elected, 76.1% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: Jody Bilney | Withhold | FOR — 4 of 4 Brighthouse funds | For | Elected, 76.1% support |
| Marex Group Plc | 2026-05-21 | Approve Scheme of Arrangement | Against | FOR — 4 of 4 Brighthouse funds | For | — |
| Guardant Health, Inc. | 2026-06-17 | Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. | For | ABSTAIN — 3 of 3 Brighthouse funds | For | — |
| Tarsus Pharmaceuticals, Inc. | 2026-06-25 | To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. Pyott | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Elected, 96.7% support |
| Wave Life Sciences Ltd. | 2025-08-05 | To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement. | Against | FOR — 3 of 3 Brighthouse funds | For | Approved, 81.1% support |
| Wave Life Sciences Ltd. | 2025-08-05 | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. | Against | FOR — 3 of 3 Brighthouse funds | For | Approved, 78.2% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | 2 wordings Re-election of Class I directors: Julian Baker | For | WITHHOLD — 4 of 5 Brighthouse funds | For | Elected, 88.6% support |
| Meritage Homes Corporation | 2026-05-21 | Shareholder Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. | For | ABSTAIN or AGAINST — 4 of 5 Brighthouse funds | Against | Not approved, 25.6% support |
| Asbury Automotive Group, Inc. | 2026-05-04 | Shareholder Stockholder proposal regarding special stockholder meetings. | For | AGAINST or ABSTAIN — 4 of 5 Brighthouse funds | Against | Not approved, 23.8% support |
| Apogee Therapeutics, Inc. | 2026-06-09 | Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr. | Withhold | FOR — 4 of 5 Brighthouse funds | For | Passed (calculated), 81.5% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Election of Directors: Daniel E. Berce | For | ABSTAIN or AGAINST — 5 of 7 Brighthouse funds | For | Passed (calculated), 94.3% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Election of Directors: Mikel D. Faulkner | For | ABSTAIN or AGAINST — 5 of 7 Brighthouse funds | For | Passed (calculated), 92.4% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Election of Directors: Randel G. Owen | For | ABSTAIN or AGAINST — 5 of 7 Brighthouse funds | For | Passed (calculated), 87.7% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Robert E. Knowling, Jr. | For | WITHHOLD — 5 of 7 Brighthouse funds | For | Elected, 96.1% support |
| Glaukos Corporation | 2026-05-28 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | For | ABSTAIN or AGAINST — 5 of 8 Brighthouse funds | For | Passed (calculated), 91.8% support |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Michael T. Miller | For | AGAINST or ABSTAIN — 5 of 8 Brighthouse funds | For | Elected, 96.1% support |
| Calix, Inc. | 2026-05-14 | Shareholder To hold an advisory vote on a stockholder proposal relating to a simple majority vote. | For | ABSTAIN or AGAINST — 5 of 8 Brighthouse funds | Against | Passed (calculated), 90.8% support |
| Zurn Elkay Water Solutions Corporation | 2026-04-30 | Ratification of the selection of Ernst & Young LLP as Zurn Elkay's independent registered public accounting firm for the year ending December 31, 2026. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Passed (calculated), 98.1% support |
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey | Withhold | FOR — 3 of 4 Brighthouse funds | For | Elected, 86.8% support |
| FormFactor, Inc. | 2026-05-15 | Amendment to FormFactor's Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation. | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Approved, 87.7% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David Hallal | Withhold | FOR — 3 of 4 Brighthouse funds | For | Elected, 86.5% support |
| Granite Construction Incorporated | 2026-06-04 | Election of Directors: Carlos M. Hernandez | For | ABSTAIN or AGAINST — 3 of 4 Brighthouse funds | For | Passed (calculated), 96.1% support |
| Granite Construction Incorporated | 2026-06-04 | Election of Directors: Celeste B. Mastin | For | ABSTAIN or AGAINST — 3 of 4 Brighthouse funds | For | Passed (calculated), 94.6% support |
| VSE Corporation | 2026-05-07 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | For | AGAINST or ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 78.4% support |
| Edgewise Therapeutics, Inc. | 2026-06-04 | Conduct an advisory vote on the compensation of our named executive officers. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 96.1% support |
| Edgewise Therapeutics, Inc. | 2026-06-04 | Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 100.0% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Jeffrey N. Edwards | For | AGAINST or ABSTAIN — 3 of 4 Brighthouse funds | For | Elected, 82.1% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Lisa Myers | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 85.4% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Maryam Banikarim | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 81.2% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Ajay Mehra | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 97.4% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Deepak Chopra | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 97.1% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Gerald Chizever | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 89.8% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Kelli Bernard | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 93.6% support |
| Extreme Networks, Inc. | 2025-11-12 | Approve an amendment and restatement of the Extreme Networks, Inc. 2013 Equity Incentive plan to add 6,800,000 shares of our common stock to those reserved for issuance under the plan. | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | — |
| Vera Therapeutics, Inc. | 2026-05-21 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 95.9% support |
| Vera Therapeutics, Inc. | 2026-05-21 | To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 99.9% support |
| The Bancorp, Inc. | 2026-05-27 | Election of ten directors to serve for a term of one year until the 2027 annual meeting of stockholders: Cheryl D. Creuzot | For | ABSTAIN or AGAINST — 3 of 4 Brighthouse funds | For | Passed (calculated), 96.2% support |
| The Bancorp, Inc. | 2026-05-27 | Election of ten directors to serve for a term of one year until the 2027 annual meeting of stockholders: Matthew N. Cohn | For | ABSTAIN or AGAINST — 3 of 4 Brighthouse funds | For | Passed (calculated), 97.2% support |
| The Bancorp, Inc. | 2026-05-27 | Election of ten directors to serve for a term of one year until the 2027 annual meeting of stockholders: William H. Lamb | For | ABSTAIN or AGAINST — 3 of 4 Brighthouse funds | For | Passed (calculated), 96.8% support |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Passed (calculated), 96.4% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Charles Kissner | For | AGAINST or ABSTAIN — 6 of 11 Brighthouse funds | For | Passed (calculated), 85.5% support |
| Kratos Defense & Security Solutions, Inc. | 2026-05-12 | To approve an amendment to the Company's Certificate of Incorporation to provide for officer exculpation. | For | ABSTAIN or AGAINST — 6 of 11 Brighthouse funds | For | Approved, 88.6% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Approve, by non-binding vote, the compensation of named executive officers as described in the Proxy Statement. | For | ABSTAIN — 4 of 7 Brighthouse funds | For | Approved, 96.7% support |
| FirstCash Holdings, Inc. | 2026-06-09 | To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. | For | ABSTAIN — 4 of 7 Brighthouse funds | For | Approved, 97.5% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Aida M. Alvarez | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 97.8% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Allison Lawrence | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 98.1% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Joseph A. Verbrugge | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 97.9% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Liza McFadden | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 93.6% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Ralph Smith | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 98.2% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Steven B. Fink | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 95.2% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Advisory vote to approve executive compensation | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 97.1% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan | For | AGAINST — 3 of 5 Brighthouse funds | For | — |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Re-election of Class I directors: Daniel Brennan | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Elected, 99.4% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 99.8% support |
| Krystal Biotech, Inc. | 2026-05-15 | Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 95.6% support |
| Krystal Biotech, Inc. | 2026-05-15 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 99.9% support |
| Protagonist Therapeutics, Inc. | 2026-06-17 | To approve the adoption of the Company's 2026 Equity Incentive Plan. | Against | FOR — 3 of 5 Brighthouse funds | For | Approved, 84.4% support |
| Semtech Corporation | 2026-06-04 | Approve the amendment and restatement of the Semtech Corporation 2017 Long-Term Equity Incentive Plan. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Passed (calculated), 98.0% support |
| Semtech Corporation | 2026-06-04 | Approve, on an advisory basis, the Company's executive compensation. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Passed (calculated), 97.6% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Gregory M. Fischer | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Hong Q. Hou | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.7% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Julie G. Ruehl | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.7% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Martin S.J. Burvill | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.1% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Paul V. Walsh, Jr. | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Paula LuPriore | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Rodolpho C. Cardenuto | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Saar Gillai | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.3% support |
| Semtech Corporation | 2026-06-04 | Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Ye Jane Li | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 98.8% support |
| Semtech Corporation | 2026-06-04 | Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for fiscal year 2027. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Amin N. Maredia | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Edward N. Antoian | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 97.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Harry S. Cherken, Jr. | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 98.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: John C. Mulliken | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 97.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Kelly Campbell | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.3% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Mary C. Egan | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Todd R. Morgenfeld | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 99.1% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Wesley S. McDonald | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 98.3% support |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirr | Withhold | FOR — 3 of 5 Brighthouse funds | For | Passed (calculated), 85.9% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Brian White | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.3% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Jorge Titinger | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 98.0% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Kelley Steven-Waiss | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 98.5% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Michael D. Slessor | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.4% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Rebeca Obregon Jimenez | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.8% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Sheri Rhodes | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.8% support |
| FormFactor, Inc. | 2026-05-15 | Election of Directors: Thomas St. Dennis | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 95.4% support |
| Dianthus Therapeutics, Inc. | 2026-05-21 | To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge | Withhold | FOR — 3 of 5 Brighthouse funds | For | Passed (calculated), 80.6% support |
| CorVel Corporation | 2025-08-07 | To approve the 2025 Stock Incentive Plan. | Against | FOR — 3 of 5 Brighthouse funds | For | Passed (calculated), 84.0% support |
| Chesapeake Utilities Corporation | 2026-05-06 | Approve on an advisory non-binding basis the compensation of the Company's Named Executive Officers. | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | — |
| Group 1 Automotive, Inc. | 2026-05-12 | Shareholder Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. | For | AGAINST or ABSTAIN — 3 of 5 Brighthouse funds | Against | Not approved, 25.3% support |
| AtriCure, Inc. | 2026-05-18 | Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 95.9% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: B. Kristine Johnson | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.0% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Deborah H. Telman | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 97.2% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Karen N. Prange | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 98.6% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Maggie Yuen | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 98.4% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Michael H. Carrel | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.4% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Regina E. Groves | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.4% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Robert S. White | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 97.4% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Shlomo Nachman | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.4% support |
| AtriCure, Inc. | 2026-05-18 | Election of Directors: Sven A. Wehrwein | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 98.4% support |
| AtriCure, Inc. | 2026-05-18 | Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. | For | AGAINST — 3 of 5 Brighthouse funds | For | — |
| AtriCure, Inc. | 2026-05-18 | Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | — |
| AtriCure, Inc. | 2026-05-18 | Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 94.9% support |
| Constellium SE | 2026-05-21 | Re-appointment of Mr. John Ormerod as a director for a term of three years | For | ABSTAIN or AGAINST — 3 of 5 Brighthouse funds | For | Passed (calculated), 83.8% support |
| Blue Bird Corporation | 2026-03-11 | To approve an amendment to our certificate of incorporation to provide for limitation of liability of certain officers for certain breaches of fiduciary duty as permitted under Delaware law. | For | AGAINST or ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 86.2% support |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | — |
| Ocular Therapeutix, Inc. | 2026-06-10 | To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 98.9% support |
| Zeta Global Holdings Corp. | 2026-06-16 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 94.9% support |
| Zeta Global Holdings Corp. | 2026-06-16 | Election of Directors: Robert Niehaus | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 97.1% support |
| Zeta Global Holdings Corp. | 2026-06-16 | Election of Directors: William Landman | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 93.7% support |
| Zeta Global Holdings Corp. | 2026-06-16 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 100.0% support |
| Silicon Laboratories Inc. | 2026-04-23 | To approve amendments to the 2009 Stock Incentive Plan; and | Against | FOR — 2 of 3 Brighthouse funds | For | Passed (calculated), 78.0% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Allan Leinwand | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 97.0% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Pamela Thomas-Graham | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 96.7% support |
| Ligand Pharmaceuticals Incorporated | 2026-06-05 | Election of Directors: Jason M. Aryeh | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 82.0% support |
| Ligand Pharmaceuticals Incorporated | 2026-06-05 | Election of Directors: John W. Kozarich, Ph.D. | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 92.7% support |
| Ligand Pharmaceuticals Incorporated | 2026-06-05 | Election of Directors: Nancy R. Gray, Ph.D. | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 96.5% support |
| Super Group (SGHC) Limited | 2026-06-25 | Authorize Market Purchases of Company Shares | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| Super Group (SGHC) Limited | 2026-06-25 | Elect Director John Le Poidevin | For | AGAINST — 2 of 3 Brighthouse funds | For | — |
| Super Group (SGHC) Limited | 2026-06-25 | Elect Director Jonathan Jossel | For | AGAINST — 2 of 3 Brighthouse funds | For | — |
| Super Group (SGHC) Limited | 2026-06-25 | Elect Director Robert James Dutnall | For | AGAINST — 2 of 3 Brighthouse funds | For | — |
| Transocean Ltd. | 2026-05-22 | Advisory Vote to Approve the Swiss Statutory Report on Non-Financial Matters for Fiscal Year 2025 | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| SSR Mining Inc. | 2026-05-07 | To approve on an advisory (non-binding) basis, the compensation of the Company's named executive officers disclosed in this Proxy Statement. | For | AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 54.3% support |
| Merit Medical Systems, Inc. | 2026-05-13 | The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term) | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Elected, 97.6% support |
| Merit Medical Systems, Inc. | 2026-05-13 | The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term) | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.8% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Jean K. Holley | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.4% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Michael A. Kelly | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 91.5% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Patrick D. Campbell | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.6% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Rakesh Sachdev | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 89.3% support |
| BGC Group, Inc. | 2025-11-12 | Approval of the ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for fiscal year 2025. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.9% support |
| CRISPR Therapeutics AG | 2026-06-04 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. | Against | FOR — 2 of 3 Brighthouse funds | For | Approved, 88.1% support |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Non-binding advisory vote on the 2025 Compensation Report. | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. | Against | FOR — 2 of 3 Brighthouse funds | For | Approved, 69.4% support |
| Erasca, Inc. | 2026-06-26 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 100.0% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: James L. Whims | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 92.3% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: Jeffrey D. Buchanan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 92.1% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: Keith B. Geeslin | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 92.2% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: Patricia Kummrow | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 90.0% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: Rahul Patel | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.1% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: Vivie Lee | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.3% support |
| Synaptics Incorporated | 2025-10-28 | Proposal to approve the Company's amended and restated 2019 Employee Stock Purchase Plan. | For | AGAINST — 2 of 3 Brighthouse funds | For | Approved, 99.7% support |
| Synaptics Incorporated | 2025-10-28 | Proposal to approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 96.0% support |
| Synaptics Incorporated | 2025-10-28 | Proposal to ratify the appointment of KPMG LLP, an independent registered public accounting firm, as the Company's independent auditor for the fiscal year ending June 27, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.7% support |
| Powell Industries, Inc. | 2026-02-18 | To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Alaina K. Brooks | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 94.3% support |
| Powell Industries, Inc. | 2026-02-18 | To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Katheryn B. Curtis | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 92.7% support |
| ServisFirst Bancshares, Inc. | 2026-05-18 | To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: Betsy Bugg Holloway | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 97.9% support |
| ServisFirst Bancshares, Inc. | 2026-05-18 | To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: Christopher J. Mettler | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 97.9% support |
| ServisFirst Bancshares, Inc. | 2026-05-18 | To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: Irma L. Tuder | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 97.7% support |
| ServisFirst Bancshares, Inc. | 2026-05-18 | To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: J. Richard Cashio | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 94.3% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Aylwin Lewis | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 73.2% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Christopher Pappas | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.5% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Debra Walton-Ruskin | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: John Pappas | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.8% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Lester Owens | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Richard N. Peretz | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Steven F. Goldstone | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.3% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | To ratify the selection of BDO USA, P.C. as our Independent registered public accounting firm for the fiscal year ending December 25, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.4% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Alan Frank | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.1% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Allen C. Puwalski | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.2% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Eli H. Miller | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.2% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Jennifer R. Whip | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.9% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Joseph Otting | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.1% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Marshall Lux | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.0% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Milton Berlinski | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.0% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Steven T. Mnuchin | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 96.0% support |
| iRhythm Holdings, Inc. | 2026-05-27 | To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Bruce Bodaken | Withhold | FOR — 2 of 3 Brighthouse funds | For | Elected, 74.1% support |
| Integer Holdings Corporation | 2026-05-20 | To approve, in an advisory non-binding vote, the compensation of our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.6% support |
| Integer Holdings Corporation | 2026-05-20 | To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.3% support |
| Franklin Electric Co., Inc. | 2026-05-08 | Approve, on an advisory basis, the frequency of future votes on the compensation of the Named Executive Officers as disclosed in the Proxy Statement. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Jody A. Markopoulos | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: John W. Kuo | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Kenneth C. Bockhorst | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Lawrence D. Kingsley | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Robert A. Cascella | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 100.0% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Ellen M. Lord | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Elected, 93.7% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Marc J. Walfish | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Elected, 90.9% support |
| The St. Joe Company | 2026-05-12 | Approval, on an advisory basis, of the compensation of our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.0% support |
| The St. Joe Company | 2026-05-12 | Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.9% support |
| Solaris Energy Infrastructure, Inc. | 2026-05-15 | Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2025. | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 86.4% support |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Yadin Rozov | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 96.8% support |
| Xenon Pharmaceuticals Inc. | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Against | FOR — 2 of 3 Brighthouse funds | For | Approved, 68.0% support |
| The Vita Coco Company, Inc. | 2026-06-03 | Election of Class II Directors: Kenneth Sadowsky | Withhold | FOR — 2 of 3 Brighthouse funds | For | Passed (calculated), 80.8% support |
| The Vita Coco Company, Inc. | 2026-06-03 | Election of Class II Directors: Michael Kirban | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 93.8% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Duncan L. Niede | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Frank A. Natoli | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.1% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Jeffry H. von G | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.6% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Joseph E. Reece | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.6% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Mary Ellen Bake | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 95.0% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Odilon Almeida, | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.4% support |
| NCR Atleos Corporation | 2026-05-21 | Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Timothy C. Oliv | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.8% support |
| Par Pacific Holdings, Inc. | 2026-04-30 | To approve the Par Pacific Holdings, Inc. 2026 Long-Term Incentive Plan. | Against | FOR — 2 of 3 Brighthouse funds | For | Passed (calculated), 70.6% support |
| The GEO Group, Inc. | 2026-04-28 | Advisory vote to approve named executive officer compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 71.6% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Donna Arduin Kauranen | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.4% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: George C. Zoley | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.4% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Jack Brewer | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 78.5% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Julie Myers Wood | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 95.5% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Lindsay L. Koren | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.2% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Scott M. Kernan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.2% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Thomas C. Bartzokis | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.3% support |
| The GEO Group, Inc. | 2026-04-28 | To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accountants for the 2026 fiscal year. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.3% support |
| Acadian Asset Management Inc. | 2026-06-11 | Advisory vote to approve executive compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 97.6% support |
| Acadian Asset Management Inc. | 2026-06-11 | Election of Directors: Andrew Kim | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 85.0% support |
| Acadian Asset Management Inc. | 2026-06-11 | Election of Directors: Barbara Trebbi | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.3% support |
| Acadian Asset Management Inc. | 2026-06-11 | Election of Directors: John Paulson | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 90.6% support |
| Acadian Asset Management Inc. | 2026-06-11 | Election of Directors: Kelly Young | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 97.3% support |
| Acadian Asset Management Inc. | 2026-06-11 | Election of Directors: Robert Chersi | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.0% support |
| Acadian Asset Management Inc. | 2026-06-11 | Ratification of the appointment of KPMG LLP as the registered public accounting firm of Acadian Asset Management Inc. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.8% support |
| Seacoast Banking Corporation of Florida | 2026-05-20 | Advisory (Non-binding) Vote on Compensation of Named Executive Officers | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Approved, 98.0% support |
| Indivior Pharmaceuticals, Inc. | 2026-05-13 | To approve, on an advisory basis, the compensation of our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.6% support |
| Indivior Pharmaceuticals, Inc. | 2026-05-13 | To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.8% support |
| Diodes Incorporated | 2026-05-11 | To elect six persons to the Board of Directors of the Company, each to serve until the next annual meeting of stockholders and until their respective successors have been elected and qualified: Huey-Jen (Jenny) Su | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 89.8% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Anne G. Saunders | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.1% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Cynthia B. Burks | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.0% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Daniel T. Carter | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.2% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: David B. Pendarvis | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.0% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Edward O. Magee, Jr. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.1% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Eric P. Etchart | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.0% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Graciela I. Monteagudo | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.0% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Lara L. Lee | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.9% support |
| WD-40 Company | 2025-12-12 | To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Steven A. Brass | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.1% support |
| Shake Shack Inc. | 2026-06-10 | Approval, on an advisory basis, of the compensation of our Named Executive Officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 93.7% support |
| Shake Shack Inc. | 2026-06-10 | Ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.7% support |
| The Marzetti Company | 2025-11-19 | To approve, by non-binding vote, the compensation of the Corporation's named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.1% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Ann G. Bordelon | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Bobby K. George | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Chris T. Sultemeier | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Eduardo F. Conrado | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.4% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Janice E. Stipp | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.5% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Judy R. McReynolds | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.2% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Michael P. Hogan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.5% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Salvatore A. Abbate | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.9% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Seth K. Runser | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| ArcBest Corporation | 2026-04-24 | Election of Directors: Thom S. Albrecht | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| Banc of California, Inc. | 2026-05-06 | Approval of the Company's Second Amended and Restated 2018 Omnibus Stock Incentive Plan. | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Approved, 98.1% support |
| Kohl's Corporation | 2026-05-20 | Management Proposal: Approve the Amended and Restated Kohl's Corporation 2024 Long-Term Compensation Plan. | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 95.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. Suggs | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 93.5% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. Forbes | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 92.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. Cerulli | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 83.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott Welch | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 93.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. Brown | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 94.3% support |
| Progyny, Inc. | 2026-05-21 | Election of Directors: Cheryl Scott | Withhold | FOR — 2 of 3 Brighthouse funds | For | Elected, 76.2% support |
| Progyny, Inc. | 2026-05-21 | Election of Directors: Kevin Gordon | Withhold | FOR — 2 of 3 Brighthouse funds | For | Elected, 80.9% support |
| Progyny, Inc. | 2026-05-21 | Election of Directors: Lloyd Dean | Withhold | FOR — 2 of 3 Brighthouse funds | For | Elected, 77.1% support |
| Vericel Corporation | 2026-04-29 | Election of Directors: Alan L. Rubino | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 89.7% support |
| Vericel Corporation | 2026-04-29 | Election of Directors: Heidi Hagen | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 83.1% support |
| Vericel Corporation | 2026-04-29 | Election of Directors: Paul K. Wotton | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 94.8% support |
| Boise Cascade Company | 2026-04-30 | Advisory vote on frequency of advisory vote regarding executive compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Amy Humphreys | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.1% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Christopher McGowan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.9% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Craig Dawson | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.2% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Duane McDougall | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.2% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Jeff Strom | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.2% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Karen Gowland | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 96.6% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Kristopher Matula | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.4% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Nate Jorgensen | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.0% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Steven Cooper | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.4% support |
| Boise Cascade Company | 2026-04-30 | Election of Directors: Sue Taylor | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.2% support |
| Trinity Industries, Inc. | 2026-05-21 | Advisory vote to approve named executive officer compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.4% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: Dunia A. Shive | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.9% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: E. Jean Savage | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.4% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: John J. Diez | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.9% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: Leldon E. Echols | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.0% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: Robert C. Biesterfeld Jr. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: S. Todd Maclin | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: Veena M. Lakkundi | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Trinity Industries, Inc. | 2026-05-21 | Election of Directors: William P. Ainsworth | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.2% support |
| Trinity Industries, Inc. | 2026-05-21 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.3% support |
| Northern Oil and Gas, Inc. | 2026-05-21 | To approve, on an advisory basis, the compensation paid to our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 96.4% support |
| Northern Oil and Gas, Inc. | 2026-05-21 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.8% support |
| HCI Group, Inc. | 2026-06-10 | Ratification of the appointment of Forvis Mazars, LLP as independent registered public accounting firm for fiscal 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.7% support |
| Interface, Inc. | 2026-05-19 | Approval, on an advisory basis, of executive compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.7% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Catherine M. Kilbane | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Catherine Marcus | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.2% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Christopher G. Kennedy | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 96.1% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Daniel T. Hendrix | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.2% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Dwight Gibson | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.8% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: John P. Burke | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.2% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Joseph Keough | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: K. David Kohler | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.4% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Laurel M. Hurd | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.7% support |
| Interface, Inc. | 2026-05-19 | Election of ten members of the Board of Directors: Robert T. O'Brien | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Interface, Inc. | 2026-05-19 | Ratification of the appointment of Ernst & Young, LLP as the Company's Independent Registered Public Accounting Firm for 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.9% support |
| WaFd, Inc. | 2026-02-03 | ADVISORY VOTE ON THE COMPENSATION OF WAFD, INC.'S NAMED EXECUTIVE OFFICERS. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 96.1% support |
| WaFd, Inc. | 2026-02-03 | RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Power Integrations, Inc. | 2026-06-03 | To approve the amendment and restatement of the Power Integrations, Inc. 2016 Incentive Award Plan to Increase the number of shares reserved for issuance thereunder. | Against | FOR — 2 of 3 Brighthouse funds | For | Approved, 83.1% support |
| NeoGenomics, Inc. | 2026-05-21 | Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. | For | AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 83.2% support |
| NeoGenomics, Inc. | 2026-05-21 | Election of the directors named in the proxy statement as set forth below: David B. Perez | For | AGAINST — 2 of 3 Brighthouse funds | For | Elected, 96.9% support |
| NeoGenomics, Inc. | 2026-05-21 | Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn | For | AGAINST — 2 of 3 Brighthouse funds | For | Elected, 97.3% support |
| NeoGenomics, Inc. | 2026-05-21 | Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault | For | AGAINST — 2 of 3 Brighthouse funds | For | Elected, 96.9% support |
| NeoGenomics, Inc. | 2026-05-21 | Election of the directors named in the proxy statement as set forth below: Michael A. Kelly | For | AGAINST — 2 of 3 Brighthouse funds | For | Elected, 94.9% support |
| Veracyte, Inc. | 2026-06-10 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.5% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.9% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 96.6% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.8% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 97.0% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.4% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 93.0% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 99.8% support |
| Veracyte, Inc. | 2026-06-10 | The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.5% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.3% support |
| Vir Biotechnology, Inc. | 2026-05-26 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | Approved, 90.1% support |
| Kaiser Aluminum Corporation | 2026-06-04 | ADVISORY VOTE TO APPROVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICER AS DISCLOSED IN THE PROXY STATEMENT | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Kaiser Aluminum Corporation | 2026-06-04 | APPROVAL OF AMENDMENT AND RESTATEMENT OF KAISER ALUMINUM CORPORATION 2021 EQUITY AND INCENTIVE COMPENSATION PLAN | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Kaiser Aluminum Corporation | 2026-06-04 | RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026 | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dana Wolf | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.5% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dhrupad Trivedi | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 95.7% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Eric Singer | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Plurality election, 47.7% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Peter Y. Chung | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 83.0% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. Braham | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.6% support |
| Trupanion, Inc. | 2026-06-10 | To approve, on a non-binding advisory basis, the compensation provided to our named executive officers for the year ended December 31, 2025. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.3% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Darryl Rawlings | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.2% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Elizabeth McLaughlin | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.4% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Howard Rubin | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.3% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Jacqueline Davidson | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.8% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Margaret Tooth | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.8% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Murray Low | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.3% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Paulette Dodson | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.9% support |
| Trupanion, Inc. | 2026-06-10 | To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Richard Enthoven | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Trupanion, Inc. | 2026-06-10 | To ratify the selection of Ernst & Young LLP as Trupanion, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.8% support |
| MillerKnoll, Inc. | 2025-10-13 | Proposal to approve, on an advisory basis, the Company's Named Executive Officer compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 95.6% support |
| MillerKnoll, Inc. | 2025-10-13 | Proposal to ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.1% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: Dana L. Schmaltz | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.0% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: Donna Wells | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 93.0% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: Ellen Levy | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 94.5% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: Ernest Freedman | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: Jeffrey R. Hayward | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.9% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: John Rice | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 96.8% support |
| Walker & Dunlop, Inc. | 2026-05-19 | Election of Directors: William M. Walker | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.6% support |
| Artivion, Inc. | 2026-05-12 | ELECTION OF DIRECTORS: Elizabeth A. Hoff | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 95.2% support |
| Artivion, Inc. | 2026-05-12 | ELECTION OF DIRECTORS: Jeffrey H. Burbank | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 87.1% support |
| Artivion, Inc. | 2026-05-12 | ELECTION OF DIRECTORS: Jon W. Salveson | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 94.9% support |
| Artivion, Inc. | 2026-05-12 | ELECTION OF DIRECTORS: Marna P. Borgstrom | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Elected, 95.2% support |
| QuinStreet, Inc. | 2025-10-30 | Approval, by advisory vote, of the compensation awarded to QuinStreet, Inc.'s named executive officers as disclosed in the proxy statement. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 97.3% support |
| QuinStreet, Inc. | 2025-10-30 | Election of Directors: David Pauldine | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.9% support |
| QuinStreet, Inc. | 2025-10-30 | Election of Directors: James Simons | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 88.4% support |
| QuinStreet, Inc. | 2025-10-30 | Election of Directors: Stuart M. Huizinga | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.0% support |
| QuinStreet, Inc. | 2025-10-30 | Ratification of the appointment of PricewaterhouseCoopers LLP as QuinStreet, Inc.'s independent registered public accounting firm for the fiscal year ending June 30, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.7% support |
| Grid Dynamics Holdings, Inc. | 2025-12-23 | The approval of 3,500,000 additional shares under the Grid Dynamics Holdings, Inc. 2020 Equity Incentive Plan. | Against | FOR — 2 of 3 Brighthouse funds | For | Approved, 68.4% support |
| Grid Dynamics Holdings, Inc. | 2025-12-23 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Against | FOR — 2 of 3 Brighthouse funds | For | Approved, 56.8% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: Dana Crandall | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: David Krall | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.5% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: Deborah L. Clifford | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.4% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: Neel Dev | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: Nimrod Ben-Natan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.7% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: Patrick Gallagher | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 97.6% support |
| Harmonic Inc. | 2026-06-04 | Election of Directors: Stephanie Copeland | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 99.6% support |
| Harmonic Inc. | 2026-06-04 | To approve, on an advisory basis, the compensation of the named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 97.2% support |
| Harmonic Inc. | 2026-06-04 | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.8% support |
| Janux Therapeutics, Inc. | 2026-06-11 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 90.3% support |
| Janux Therapeutics, Inc. | 2026-06-11 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.8% support |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| Wave Life Sciences Ltd. | 2025-08-05 | The election of the nominees for director: Christian Henry | For | AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 85.4% support |
| Wave Life Sciences Ltd. | 2025-08-05 | The election of the nominees for director: Ken Takanashi | For | AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 95.4% support |
| Hertz Global Holdings, Inc. | 2026-05-28 | Approval, on an advisory basis, of the compensation of our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 98.3% support |
| Hertz Global Holdings, Inc. | 2026-05-28 | Election of the two director nominees identified in the Company's Proxy Statement to serve as directors for the three-year term expiring at the Company's 2029 annual meeting of stockholders: Lucy Clark Dougherty | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 98.9% support |
| Hertz Global Holdings, Inc. | 2026-05-28 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.1% support |
| Aclaris Therapeutics, Inc. | 2026-06-04 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2026. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.9% support |
| Verra Mobility Corporation | 2026-05-19 | Approve, on an advisory basis (non-binding), the frequency of future advisory votes approving the compensation of our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| CSG Systems International, Inc. | 2026-01-30 | To adjourn the special meeting from time to time, if necessary or appropriate, as determined in accordance with the merger agreement by the CSG board of directors, including for the purpose of soliciting additional votes for the approval of the merger proposal if there are insufficient votes at the | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| CSG Systems International, Inc. | 2026-01-30 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to named executive officers of CSG in connection with the consummation of the merger; and | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Passed (calculated), 68.9% support |
| Navient Corporation | 2026-06-04 | Approve, in a non-binding advisory vote, the compensation paid to Navient-named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 97.3% support |
| Navient Corporation | 2026-06-04 | Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Anna Escobedo Cabral | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 97.7% support |
| Navient Corporation | 2026-06-04 | Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: David L. Yowan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.4% support |
| Navient Corporation | 2026-06-04 | Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Edward J. Bramson | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 98.1% support |
| Navient Corporation | 2026-06-04 | Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Frederick Arnold | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 97.3% support |
| Navient Corporation | 2026-06-04 | Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Larry A. Klane | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 94.2% support |
| Navient Corporation | 2026-06-04 | Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Michael A. Lawson | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Elected, 96.9% support |
| Navient Corporation | 2026-06-04 | Ratify the appointment of KPMG LLP as Navient independent registered public accounting firm for 2026 | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 99.2% support |
| NV5 Global, Inc. | 2025-07-31 | To approve, on a non-binding, advisory basis, the compensation that will or may be paid to NV5's named executive officers in connection with the transactions contemplated by the Merger Agreement; and. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | Approved, 94.5% support |
| The RealReal, Inc. | 2026-06-10 | Approval of a management proposal to amend our Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to the Delaware General Corporation Law. | For | ABSTAIN or AGAINST — 2 of 3 Brighthouse funds | For | — |
Download all 381 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 92.2% of this fund’s 14,390 such votes could be given a sector; the other 1,121 (7.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 3,058 | 263 | 8.6% |
| Consumer Discretionary | 2,472 | 297 | 12.0% |
| Health Care | 2,249 | 441 | 19.6% |
| Industrials | 1,459 | 121 | 8.3% |
| Technology | 1,351 | 221 | 16.4% |
| Real Estate | 838 | 77 | 9.2% |
| Energy | 598 | 54 | 9.0% |
| Utilities | 373 | 17 | 4.6% |
| Consumer Staples | 250 | 49 | 19.6% |
| Basic Materials | 236 | 14 | 5.9% |
| Miscellaneous | 201 | 21 | 10.4% |
| Telecommunications | 184 | 35 | 19.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 9,757 | 1,408 |
| Say-on-Pay | 1,700 | 197 |
| Audit-related | 1,670 | 0 |
| Compensation | 582 | 182 |
| Corporate Governance | 417 | 50 |
| Extraordinary Transactions | 191 | 13 |
| Capital Structure | 177 | 24 |
| Shareholder Rights and Defenses | 46 | 3 |
| Other | 13 | 0 |
| Other Social Issues | 3 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $12M | 8 | 2 |
| Guardant Health, Inc. | June 17, 2026 | $6M | 5 | 2 |
| agilon health, inc. | March 17, 2026 | $5M | 2 | 0 |
| Nextracker Inc. | August 18, 2025 | $5M | 5 | 1 |
| Glaukos Corporation | May 28, 2026 | $4M | 4 | 1 |
| The Ensign Group, Inc. | May 13, 2026 | $3M | 6 | 0 |
| UMB Financial Corporation | April 28, 2026 | $3M | 17 | 0 |
| Watts Water Technologies, Inc. | May 19, 2026 | $3M | 11 | 6 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 21, 2026 | Bloom Energy Corporation | Election of our four Class II Directors: Barbara Burger | Withhold | For |
| May 21, 2026 | Bloom Energy Corporation | Election of our four Class II Directors: Eddy Zervigon | Withhold | For |
| June 17, 2026 | Guardant Health, Inc. | Election of Class II Directors: Ian Clark | Withhold | For |
| June 17, 2026 | Guardant Health, Inc. | Election of Class II Directors: Manuel Hidalgo Medina | Withhold | For |
| August 18, 2025 | Nextracker Inc. | The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey Guldner | Withhold | For |
| May 28, 2026 | Glaukos Corporation | Election of Directors: Denice M. Torres | Withhold | For |
| May 19, 2026 | Watts Water Technologies, Inc. | Election of Directors: Rebecca J. Boll | Withhold | For |
| May 19, 2026 | Watts Water Technologies, Inc. | Election of Directors: Michael J. Dubose | Withhold | For |
| May 29, 2026 | SiTime Corporation | To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement. | Against | For |
| June 11, 2026 | TG Therapeutics, Inc. | Election of Directors: Laurence Charney | Withhold | For |
| June 11, 2026 | TG Therapeutics, Inc. | Election of Directors: Yann Echelard | Withhold | For |
| May 21, 2026 | BrightSpring Health Services, Inc. | Election of Class II directors: Olivia Kirtley | Withhold | For |
Meetings with a proxy contest or competing nominees (12 in 2025-2026), and how the fund voted the items on its ballot.
14,562 ballot items at 1,845 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, MetLife Russell 2000 Index Portfolio voted at 1,845 shareholder meetings of 1,746 companies, on 14,562 ballot items in all. Where management made a recommendation, the fund followed it on 86.9% of the items and voted against it 1,879 times. Its most frequent area of disagreement was director elections (1,408 of its votes against management). It voted on 76 shareholder proposals. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (86.9% against 76.3%). It voted differently from most Brighthouse funds on 381 items. 12 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.